Infection and Drug Resistance
Volume 15, 2022 - Issue
Open access
320
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH
The Risk of Emerging Resistance to Trimethoprim/Sulfamethoxazole in Staphylococcus aureus
Takumi SatoDivision of Clinical Infectious Diseases & Chemotherapy, Tohoku Medical and Pharmaceutical University, Sendai, JapanCorrespondence[email protected]
https://orcid.org/0000-0003-4277-0583View further author information
, https://orcid.org/0000-0003-4277-0583View further author information
Ryota ItoDivision of Clinical Infectious Diseases & Chemotherapy, Tohoku Medical and Pharmaceutical University, Sendai, JapanView further author information
, Masato KawamuraDivision of Clinical Infectious Diseases & Chemotherapy, Tohoku Medical and Pharmaceutical University, Sendai, Japanhttps://orcid.org/0000-0003-1863-1241View further author information
& Shigeru FujimuraDivision of Clinical Infectious Diseases & Chemotherapy, Tohoku Medical and Pharmaceutical University, Sendai, JapanView further author information
Pages 4779-4784
|
Published online: 23 Aug 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.